{"id":2332,"date":"2022-03-24T10:10:47","date_gmt":"2022-03-24T10:10:47","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/?p=2332"},"modified":"2023-02-14T10:16:01","modified_gmt":"2023-02-14T10:16:01","slug":"immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/","title":{"rendered":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2332\" class=\"elementor elementor-2332\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9497965 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"9497965\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-53f4d8f\" data-id=\"53f4d8f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f8124ab elementor-widget elementor-widget-text-editor\" data-id=\"f8124ab\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Miriam Merad, MD, PhD, Oncologist and Director of the Precision Immunology Institute at Mount Sinai in New-York is an expert of tissue-resident immune cells in cancer. Here, she discusses how the reprogrammation of these cells (macrophages, dendritic cells, &#8230;) could be used as a therapeutic modality in immuno-oncology.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0d52e70 elementor-widget elementor-widget-video\" data-id=\"0d52e70\" data-element_type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/PpAHdE-mgvk&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-62d0912 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"62d0912\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-40bd1e5\" data-id=\"40bd1e5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d155f1e elementor-widget elementor-widget-text-editor\" data-id=\"d155f1e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>Transcript:<\/b><\/p><p>\u00a0<\/p><p>Gene editing in the context of immune resident cells, like to promote one type of macrophage that is more immuno-modulatory versus one that would be more recruiting, do you see something relevant here ? Absolutely, this is a big focus of the group here, the reprogramming of macrophage and dendritic cells in the tumor lesions. So in the tumor microenvironment if we go back to cancer for a minute which is really the main focus of my lab, we also study inflammatory diseases but is to harness this macrophage and dendritic cells and make them more immunogenic. And for us, the way to do that is not to transfer more cells but to go directly and to edit them locally. We could also transfer some groups are doing it, we don&#8217;t do that. We just want to try to reprogram them. So you can reprogram them by blocking some checkpoint molecule, this is what James Allison and Tasuku Honjo discovered for T cells, where they block, you know, one checkpoint and they make them more active. Or you can edit them, so you can instead of just blocking one molecule, you can enforce the expression of a group of molecules, using, you know, different types of technology. You have heard of these mRNA vaccines, the sucess of mRNA vaccines has really energized the field of nanoparticle delivery. You know what&#8217;s very interesting about macrophages and dendritic cells is that they can eat very well, they can eat even very large particles. All cells can eat. You know, some can take up cellular compartments. But here, the uniqueness of a group of cells which are called phagocytes &#8211; macrophages and dendritic cells are part of this phagocyte group, neutrophils is another phagocyte cellular compartment &#8211; they can eat very large particles. So if you can play on this, what you can do is deliver, let&#8217;s say nanoparticles of big size, that contain different types of mRNA instructions. And here you can somehow redirect or reprogram dendritic cells and macrophages that have been shut\u00a0down by tumor metabolites for example, or tumor cues. And this is quite\u00a0exciting, many of us are looking into this.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-04e2a5c elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"04e2a5c\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8ae3fd2\" data-id=\"8ae3fd2\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-09536d0 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"09536d0\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-md\" href=\"https:\/\/youtu.be\/dbkg70JE0Xk\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">WATCH FULL VIDEO<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Miriam Merad, MD, PhD, Oncologist and Director of the Precision Immunology Institute at Mount Sinai in New-York is an expert of tissue-resident immune cells in cancer. Here, she discusses how the reprogrammation of these cells (macrophages, dendritic cells, &#8230;) could be used as a therapeutic modality in immuno-oncology.<\/p>\n","protected":false},"author":1,"featured_media":2334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Miriam Merad, MD, PhD, Oncologist and Director of the Precision Immunology Institute at Mount Sinai in New-York is an expert of tissue-resident immune cells in cancer. Here, she discusses how the reprogrammation of these cells (macrophages, dendritic cells, ...) could be used as a therapeutic modality in immuno-oncology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\" \/>\n<meta property=\"og:site_name\" content=\"Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-24T10:10:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-14T10:16:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2023\/03\/miniatures-youtube7_Plan-de-travail-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Piergueritona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@treefrogtx\" \/>\n<meta name=\"twitter:site\" content=\"@treefrogtx\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\"},\"author\":{\"name\":\"Piergueritona\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\"},\"headline\":\"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle\",\"datePublished\":\"2022-03-24T10:10:47+00:00\",\"dateModified\":\"2023-02-14T10:16:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\"},\"wordCount\":431,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization\"},\"articleSection\":[\"Videos\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\",\"name\":\"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#website\"},\"datePublished\":\"2022-03-24T10:10:47+00:00\",\"dateModified\":\"2023-02-14T10:16:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#website\",\"url\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/\",\"name\":\"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\",\"description\":\"In The Stem Cell Jungle Blog\",\"publisher\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization\",\"name\":\"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\",\"url\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2022\/09\/t2Dmvts8-Copie.png\",\"contentUrl\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2022\/09\/t2Dmvts8-Copie.png\",\"width\":686,\"height\":607,\"caption\":\"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics\"},\"image\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/twitter.com\/treefrogtx\",\"https:\/\/www.linkedin.com\/company\/treefrog-therapeutics\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\",\"name\":\"Piergueritona\",\"sameAs\":[\"https:\/\/preprod.treefrog.fr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","og_description":"Miriam Merad, MD, PhD, Oncologist and Director of the Precision Immunology Institute at Mount Sinai in New-York is an expert of tissue-resident immune cells in cancer. Here, she discusses how the reprogrammation of these cells (macrophages, dendritic cells, ...) could be used as a therapeutic modality in immuno-oncology.","og_url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/","og_site_name":"Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","article_published_time":"2022-03-24T10:10:47+00:00","article_modified_time":"2023-02-14T10:16:01+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2023\/03\/miniatures-youtube7_Plan-de-travail-1.jpg","type":"image\/jpeg"}],"author":"Piergueritona","twitter_card":"summary_large_image","twitter_creator":"@treefrogtx","twitter_site":"@treefrogtx","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#article","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/"},"author":{"name":"Piergueritona","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220"},"headline":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle","datePublished":"2022-03-24T10:10:47+00:00","dateModified":"2023-02-14T10:16:01+00:00","mainEntityOfPage":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/"},"wordCount":431,"commentCount":0,"publisher":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization"},"articleSection":["Videos"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/","url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/","name":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle - Stem Cells &amp; Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#website"},"datePublished":"2022-03-24T10:10:47+00:00","dateModified":"2023-02-14T10:16:01+00:00","breadcrumb":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/immuno-oncology-reprogramming-tissue-resident-immune-cells-in-vivo-with-mrna-miriam-merad-stem-cell-jungle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/"},{"@type":"ListItem","position":2,"name":"Immuno-oncology: Reprogramming tissue-resident immune cells in vivo with mRNA | Miriam Merad | Stem Cell Jungle"}]},{"@type":"WebSite","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#website","url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/","name":"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","description":"In The Stem Cell Jungle Blog","publisher":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#organization","name":"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics","url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/logo\/image\/","url":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2022\/09\/t2Dmvts8-Copie.png","contentUrl":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-content\/uploads\/sites\/5\/2022\/09\/t2Dmvts8-Copie.png","width":686,"height":607,"caption":"Stem Cells and Cell Therapy Blog I In the Stem Cell Jungle I iPSCs I TreeFrog Therapeutics"},"image":{"@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/twitter.com\/treefrogtx","https:\/\/www.linkedin.com\/company\/treefrog-therapeutics\/"]},{"@type":"Person","@id":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220","name":"Piergueritona","sameAs":["https:\/\/preprod.treefrog.fr"]}]}},"_links":{"self":[{"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/posts\/2332"}],"collection":[{"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/comments?post=2332"}],"version-history":[{"count":11,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/posts\/2332\/revisions"}],"predecessor-version":[{"id":2344,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/posts\/2332\/revisions\/2344"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/media\/2334"}],"wp:attachment":[{"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/media?parent=2332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/categories?post=2332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/stemcelljungle\/wp-json\/wp\/v2\/tags?post=2332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}